Correlation Between Arcellx and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcellx and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and C4 Therapeutics, you can compare the effects of market volatilities on Arcellx and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and C4 Therapeutics.

Diversification Opportunities for Arcellx and C4 Therapeutics

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Arcellx and CCCC is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Arcellx i.e., Arcellx and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Arcellx and C4 Therapeutics

Given the investment horizon of 90 days Arcellx is expected to generate 0.63 times more return on investment than C4 Therapeutics. However, Arcellx is 1.58 times less risky than C4 Therapeutics. It trades about -0.15 of its potential returns per unit of risk. C4 Therapeutics is currently generating about -0.13 per unit of risk. If you would invest  8,907  in Arcellx on September 28, 2024 and sell it today you would lose (1,104) from holding Arcellx or give up 12.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Arcellx  vs.  C4 Therapeutics

 Performance 
       Timeline  
Arcellx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcellx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Arcellx is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Arcellx and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcellx and C4 Therapeutics

The main advantage of trading using opposite Arcellx and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Arcellx and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets